© Globe Newswire
29.12.2025
COO
LISTED
NYSE
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
News Preview
SAN RAMON, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will participate at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Al White, President and CEO, will represent the Company in a session scheduled to begin at 5:15pm ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
NYXH
LISTED
NASDAQ
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
ICNAF
LISTED
OTC
LEEF Brands Announces Full Early Conversion of CAD Convertible Debentures
News Preview
LEEF Brands announces full early conversion of CAD-denominated convertible debentures, strengthening its balance sheet and improving financial flexibility....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
29.12.2025
ALVO
LISTED
ICE
Changes in company's own shares
News Preview
Attached is a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding changes in company's own shares....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ActuNews
29.12.2025
BLC
LISTED
EURONEXT
BASTIDE : Descriptif du programme de rachat d'actions voté en Assemblée générale mixte du 19 décembre 2025
News Preview
BASTIDE
Société anonyme au capital de 3.360.847,05 euros
Siège social :
12, avenue de la Dame, Zone euro 2000
30132 Caissargues
305 635 039 RCS NIMES
Descriptif du programme de rachat d'actions voté par les actionnaires
lors de l'Assemblée Générale Mixte du 19 décembre 2025
Confor...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
AVTR
LISTED
NYSE
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
This press rele...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.12.2025
DRMA
LISTED
NASDAQ
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
News Preview
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of warrants SAN DIEGO, CA / ACCESS Newswire / December 29, 2025 / Dermata Therapeutics, Inc. (Nasdaq:DRMA)(Nasdaq:DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, tod...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
CODX
LISTED
NASDAQ
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
News Preview
The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, Dec. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announc...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
WAY
LISTED
NASDAQ
Waystar to Present at J.P. Morgan Healthcare Conference
News Preview
LEHI, Utah and LOUISVILLE, Ky., Dec. 29, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT....
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
IBRX
LISTED
NASDAQ
ImmunityBio Founder Dr. Patrick Soon-Shiong Recognized as One of “100 Most Influential People in Oncology in 2025”
News Preview
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that OncoDaily has recognized Dr. Patrick Soon-Shiong as being one of “The 100 Most Influential People in Oncology in 2025.” Soon-Shiong is the company’s Founder, Executive Chairman and Global Chief Scientific and Medical Officer, and is a global thought le...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific SE: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
29.12.2025
MTVA
LISTED
NASDAQ
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference
News Preview
CAMBRIDGE, Mass., Dec. 29, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will participate in and sponsor the 10th Annual MASH-TAG 2026 Conference. Members of MetaVia's business development and clinical teams will attend the conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
SNDA
LISTED
NYSE
Sonida Senior Living Celebrates Grand Opening and a New Era of Trusted Memory Care at Magnolia Trails at East Lake
News Preview
Magnolia Trails at East Lake celebrated its grand opening on November 13, marking an exciting new chapter for families seeking trustworthy and high-quality memory care in Tarpon Springs, FL. More than 120 guests attended, including the Tarpon Springs Chamber of Commerce and over 65 healthcare partners from across the Tampa Bay region. The event sh...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
GMAB
LISTED
NASDAQ
Genmab Portfolio Prioritization Update
News Preview
Genmab A/S (Nasdaq: GMAB) announced today that it will discontinue further clinical development of acasunlimab. This decision was made as part of Genmab’s strategic focus on the most value‑creating opportunities in its late‑stage portfolio and following a thorough assessment of the evolving competitive landscape. While the clinical profile observe...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
INO
LISTED
NASDAQ
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
News Preview
PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) accepted the company's Biologics Lic...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
AZTA
LISTED
NASDAQ
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
News Preview
BURLINGTON, Mass., Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to THELEMA S.À R.L., for a purchase price of US$63 million. The transaction is expected to close on or before March 31, 2026."The ag...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
NTRB
LISTED
NASDAQ
Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
News Preview
Nutriband signs agreement to sell majority stake in Pocono for $5M...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
ENVB
LISTED
NASDAQ
Enveric Biosciences Announces Patent Issuance
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced the issuance of U.S. Patent No. 12,492,179 entitled, “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives” (the “‘179 pa...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
ESTA
LISTED
NASDAQ
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted Motiva® implants for approval in primary and revision breast reconstruction to the U.S. Food and Drug Administration (FDA...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
GEHC
LISTED
NASDAQ
GE HealthCare management to present at upcoming investor conference
News Preview
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the JP Morgan 44th Annual Healthcare Conference in San Francisco, CA on January 13, 2026, at 10:30 a.m. PT/1:30 p.m. ET/12:30 p.m. CT.
A webcast of this event can be accessed at the GE HealthCare website: https://investor.gehealthcare.com/news-events/ev...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
JNJ
LISTED
NYSE
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
News Preview
Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (“Halda”), a clinical-stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera (RIPTAC™) platform to develop oral, targeted therapies for multiple types of solid tumors,...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
MREO
LISTED
NASDAQ
Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta
News Preview
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC)...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
RARE
LISTED
NASDAQ
Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta
News Preview
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates (Cosmic)...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
MCTA
LISTED
NASDAQ
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MCTA
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of MCTA duri...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
MRM
LISTED
NASDAQ
MEDIROM Partners with World on Technology Envisioned by Sam Altman and Alex Blania: Deploying “Proof of Human” Infrastructure throughout Japan
News Preview
TOKYO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), a diversified healthcare company, collaborating with World Foundation and Tools for Humanity to deploy Proof of Human technologies such as World ID throughout Japan. The World pro...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
GMAB
LISTED
CPH
Genmab Portfolio Prioritization Update
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
SXTP
LISTED
NASDAQ
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
News Preview
Peer-reviewed NC State study found Babesia in 24% of chronic fatigue patients, supporting further study of chronic babesiosis and ARAKODA® evaluation....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
News Preview
The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential tremor...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
RVPH
LISTED
NASDAQ
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
News Preview
CUPERTINO, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced Laxminaray...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morg...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
CNVI
LISTED
TSX
Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights
News Preview
TORONTO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today reported financial results and provided an operation...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
ZVRA
LISTED
NASDAQ
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
News Preview
CELEBRATION, Fla., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has executed an exclusive expanded access distribution agreement with Uniphar, an Ireland-based phar...
Themefolio
Profiler
Peergroup
© BusinessWire
29.12.2025
HSIC
LISTED
NASDAQ
Henry Schein to Participate in the J.P. Morgan Conference in January
News Preview
Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in January:
J.P. Morgan’s Healthcare Investor Conference on Tuesday, January 13, 2026, at 3:00 p.m. PST / 6:00 p.m. EST, at The Westin St....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
UNCY
LISTED
NASDAQ
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
News Preview
New PDUFA date expected in 1H 2026 within 30 days of NDA resubmission New PDUFA date expected in 1H 2026 within 30 days of NDA resubmission...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
INDP
LISTED
NASDAQ
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
News Preview
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announces it has entered into a $6 million securities purchase agreement with investor, David E. Lazar, for the...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
GLSI
LISTED
NASDAQ
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026
News Preview
STAFFORD, Texas, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that its Board o...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.12.2025
MDCE
LISTED
OTC
Medical Care Technologies (OTC PINK:MDCE) Achieves Global Distribution Approval from Apple's iOS App Store
News Preview
MESA, AZ / ACCESS Newswire / December 29, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a technology-driven innovator in AI-powered consumer and health applications, today announced that its first international artificial intelligence ("AI") based mobile application has been officially approved by Apple for launch and distributio...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
DMYD B
LISTED
STO
Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance
News Preview
STOCKHOLM, Dec. 29, 2025 /PRNewswire/ -- Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal, registrational Phase 3 DIAGNODE-3 trial in type 1 diabetes from 24 to 15 months, per FDA guidance, enabling the full primary efficacy readout of the trial...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
DMYD B
LISTED
STO
Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance
News Preview
STOCKHOLM, Dec. 29, 2025 /PRNewswire/ -- Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal, registrational Phase 3 DIAGNODE-3 trial in type 1 diabetes from 24 to 15 months, per FDA guidance, enabling the full primary efficacy readout of the trial...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.12.2025
13
LISTED
HKSE
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma
News Preview
— NDA supported by results from a Phase II registration trial in China —...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.12.2025
CVKD
LISTED
NASDAQ
Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On
News Preview
PONTE VEDRA, FL / ACCESS Newswire / December 29, 2025 / Every industry has its forgotten corners. In anticoagulation, those corners turned into entire neighborhoods. For years, the field centered itself around convenience drugs built for broad populations and clean commercial lines. Warfarin stayed because it always had. DOACs (direct oral anticoag...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
1873
LISTED
HKSE
Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities
News Preview
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has responded by building an integrated pharmacology platform that covers this end-to-end modality range, su...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
1873
LISTED
HKSE
Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities
News Preview
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has responded by building an integrated pharmacology platform that covers this end-to-end modality range, su...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.12.2025
AEVS
LISTED
SIX
AEVIS VICTORIA SA schliesst umfangreiche konzernweite Refinanzierung erfolgreich ab
News Preview
AEVIS VICTORIA SA
/ Schlagwort(e): Finanzierung
AEVIS VICTORIA SA schliesst umfangreiche konzernweite Refinanzierung erfolgreich ab
29.12.2025 / 07:00 CET/CEST
Pressemitteilung
Freiburg, 29. Dezember 2025
AEVIS VICTORIA SA schliesst umfangreiche konzernweite Refinanzierung erfolgreich ab
AEVIS VICTORIA SA (AEVIS) g......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.12.2025
AEVS
LISTED
SIX
AEVIS VICTORIA SA successfully completes major Group-wide refinancing
News Preview
AEVIS VICTORIA SA
/ Key word(s): Financing
AEVIS VICTORIA SA successfully completes major Group-wide refinancing
29.12.2025 / 07:00 CET/CEST
Press release
Fribourg, 29 December 2025
AEVIS VICTORIA SA successfully completes major Group-wide refinancing
AEVIS VICTORIA SA (“AEVIS”) announces the successful completion ......
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
9966
LISTED
HKSE
Alphamab Oncology Announces IND Application for a Phase II Clinical Study of HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 as First-line Treatment of Advanced Cervical Cancer was Officially Accepted by CDE
News Preview
SUZHOU, China, Dec. 29, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 immune checkpoint inhibitor) in combination with platinu...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
2142
LISTED
HKSE
Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates
News Preview
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it has entered into a long-term strategic collaboration with Yantai Lannache...
Themefolio
Profiler
Peergroup
© PR Newswire
29.12.2025
2171
LISTED
HKSE
CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
News Preview
SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submitted two separate Investigational New Drug (IND) applications to the National Medical Products Administration (NMPA) for its allogeneic BCMA-targeted CAR-T...
Themefolio
Profiler
Peergroup
© BusinessWire
28.12.2025
MCTA
LISTED
NASDAQ
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charming Medical Limited (“Charming” or “the Company”) (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.12.2025
NTHI
LISTED
NASDAQ
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
News Preview
Sponsored programming featuring commercials from Synergy CHC (NASDAQ:SNYR), HelloAxel.com (private), The Sustainable Green Team (OTC:SGTM - Waterless Garden), DataVault AI (NASDAQ:DVLT), and PetVivo (OTCQX:PETV). NEW YORK CITY, NEW YORK / ACCESS Newswire / December 27, 2025 / New to The Street, the long-running global business and financial televis...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.12.2025
SKNY
LISTED
CSE
Innovation trifft Investitionschance – LIR Life Sciences läutet eine neue Ära der Adipositasbehandlung ohne Injektion ein
News Preview
EQS-Media / 27.12.2025 / 14:04 CET/CEST
LIR Life Sciences Corp. (ISIN: CA50206C1005 | WKN: A41QA9), LIR Life Sciences oder das Unternehmen, reagiert mit einer proprietären Verabreichungstechnologie auf die weltweite Adipositas-Epidemie, die mittlerweile dramatische Ausmaße angenommen hat: Prognosen zufolge könnten bis 2035 rund vier Milliarden......
Themefolio
Profiler
Peergroup
© Newsfile
26.12.2025
VIVI
LISTED
CSE
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering
News Preview
Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medicationHighlights: Expands TempraMed's product portfolio and adds a digital component to track and record medication use. First in the world platform that turns almost every in...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.12.2025
MRM
LISTED
NASDAQ
MEDIROM Partners with World
News Preview
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.12.2025
FRX
LISTED
TSX
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)
News Preview
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025, pursuant to securities laws, it disposed of beneficial ownership of 1,000,000 common shares (a “Common Share”) of Fennec Pharmaceuti...
Themefolio
Profiler
Peergroup
© BusinessWire
26.12.2025
CDNA
LISTED
NASDAQ
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants.
On December 19, 2025, as an inducement mat...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.12.2025
OTLK
LISTED
NASDAQ
Outlook Therapeutics Announces New Employment Inducement Grants
News Preview
ISELIN, N.J., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that effective December 19, 2025, the Outlook Therapeutics, Inc. Compensation Committee of the Board of Directors gra...
Themefolio
Profiler
Peergroup
© BusinessWire
26.12.2025
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© BusinessWire
26.12.2025
FOLD
LISTED
NASDAQ
Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Amicus Therapeutics, Inc. (NasdaqGM: FOLD) to BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN). Under the terms of the proposed transaction, shareholders of Amicus will receive $14.50 in cash fo...
Themefolio
Profiler
Peergroup
© BusinessWire
26.12.2025
AVTR
LISTED
NYSE
Deadline Soon: Avantor, Inc. (AVTR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming December 29, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Clas...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
